Through CB1 and CB2, these endocannabinoids amplify lipogenesis and decrease energy expenditure, contributing to obesity (Iannotti and Vitale, 2021; Pertwee et al., 2010; Lu and Mackie, 2021). This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.